Group One Trading’s Metacrine, Inc. Common Stock MTCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-34,670
Closed -$17K 8407
2022
Q3
$17K Sell
34,670
-7,563
-18% -$3.72K ﹤0.01% 6203
2022
Q2
$21K Sell
42,233
-21,500
-34% -$10.4K ﹤0.01% 6269
2022
Q1
$39K Sell
63,733
-2,400
-4% -$1.26K ﹤0.01% 6306
2021
Q4
$45K Buy
66,133
+47,610
+257% +$84.9K ﹤0.01% 6429
2021
Q3
$64K Buy
+18,523
New +$57.8K ﹤0.01% 6339

Other funds holding MTCR

Group One Trading's MTCR Position: Q4 2022 in Review

Group One Trading sold out of Metacrine, Inc. Common Stock (MTCR) in Q4 2022, closing a stake of 34,670 shares — an estimated $17K sold.

Group One Trading first reported a position in MTCR in Q3 2021 and held it in 5 quarters. The position peaked at $64K in Q3 2021. 29 funds tracked by Wall St. Rank hold MTCR as of Q4 2022.

  • Group One Trading reported no remaining Metacrine, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Group One Trading sold 34,670 Metacrine, Inc. Common Stock shares in Q4 2022, an estimated $17K.
  • Group One Trading first reported a position in Metacrine, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • Group One Trading's Metacrine, Inc. Common Stock position peaked at $64K in Q3 2021.
  • 29 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q4 2022.

Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.